Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study.

Cell reports. Medicine·2026
Same author

Frailty identifies early and non-cardiac healthcare utilization after cardiovascular hospitalization.

Frontiers in cardiovascular medicine·2026
Same author

Circulating Adipsin as a Biomarker of Liver Fat Content in Prepubertal Children Born Small-for-Gestational-Age.

International journal of molecular sciences·2026
Same author

Factors associated with frailty in older adults hospitalized for cardiovascular disease: A multidimensional cross-sectional observational study.

Geriatric nursing (New York, N.Y.)·2026
Same author

Nurse-Led Health Education Intervention on Basic Life Support for Relatives of Patients With Cardiac Conditions: A Quasi-Experimental Pilot Study.

Nursing & health sciences·2026
Same author

Enfortumab vedotin in ECOG-PS 2 advanced urothelial carcinoma patients: a real-world study from the ARON-2<sup>EV</sup> project.

BMC cancer·2026

Related Experiment Video

Updated: Jul 3, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Primary cardiac osteosarcoma.

María López1, Alvaro Pinto, Víctor Moreno

  • 1Internal Medicine Department, Hospital La Paz, Madrid, Spain. alvaro_pinto_marin@hotmail.com

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|August 1, 2008
PubMed
Summary

Primary cardiac osteosarcoma is a rare malignant heart tumor. This case report details a 70-year-old woman with left atrial osteosarcoma, highlighting disease relapse and metastasis despite surgical removal.

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Related Experiment Videos

Last Updated: Jul 3, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Area of Science:

  • Cardiology
  • Oncology
  • Pathology

Background:

  • Primary cardiac neoplasms are rare, with sarcomas constituting over 95% of malignant cases.
  • Most heart tumors are metastatic rather than primary.
  • Osteosarcoma is an uncommon primary malignant tumor of the heart.

Observation:

  • A case of a 70-year-old woman with primary cardiac osteosarcoma originating in the left atrium is presented.
  • The patient underwent complete tumor excision.
  • Despite successful surgery, the patient experienced disease relapse and developed metastatic disease.

Findings:

  • Primary cardiac osteosarcoma, though rare, can exhibit aggressive behavior with a propensity for recurrence and metastasis.
  • Complete surgical excision may not prevent disease progression in all cases of cardiac osteosarcoma.
  • The management and therapeutic options for this rare entity require careful consideration.

Implications:

  • This case underscores the importance of vigilant follow-up for patients with primary cardiac osteosarcoma.
  • Further research into optimal therapeutic strategies for cardiac osteosarcoma is warranted.
  • Understanding the behavior of rare cardiac tumors like osteosarcoma can inform clinical decision-making and improve patient outcomes.